Seeking Alpha

GenMark Diagnostics (GNMK) falls 6.5% AH on top of 8.35% during the regular session. The company...

GenMark Diagnostics (GNMK) falls 6.5% AH on top of 8.35% during the regular session. The company says it now sees FY13 revenue of ~$30M versus the $35M it originally estimated. GNMK cites "additional uncertainties relating to the future revenue contribution from its largest customer" (previous).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)